Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | 26 | 5 | 6 | 0 | €47.83 | €56.86 | 18.884% |
| Medpace Holdings Inc | 16 | 0 | 6 | 0 | €358.00 | €418.12 | 16.794% |
| Arrowhead Pharmaceuticals Inc. | 21 | 2 | 5 | 0 | €26.67 | €54.98 | 106.153% |
| Neurocrine Bioscience | 35 | 0 | 4 | 0 | €134.65 | €143.34 | 6.457% |
| United Therapeutics | 24 | 0 | 3 | 0 | €310.20 | €299.42 | -3.476% |
| Alnylam Pharmace. | 44 | 0 | 2 | 0 | €219.30 | €253.95 | 15.802% |
| Exelixis Inc. | 20 | 0 | 2 | 0 | €20.90 | €26.01 | 24.433% |
| Acadia Pharmaceuticals | 29 | 1 | 2 | 0 | €17.14 | €31.28 | 82.554% |
| Nektar Therapeutics | 4 | 1 | 1 | 0 | €1.26 | €2.40 | 90.627% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €124.45 | €182.96 | 47.015% |
| PTC Therapeutics Inc. | 14 | 9 | 1 | 0 | €30.60 | €41.46 | 35.500% |
| Ultragenyx Pharmaceutical Inc. | 23 | 1 | 1 | 0 | €41.60 | €86.28 | 107.401% |
| Agios Pharmaceuticals Inc. | 8 | 1 | 0 | 1 | €43.80 | €48.75 | 11.300% |
| Xencor Inc. | 14 | 1 | 0 | 0 | €19.60 | €31.70 | 61.717% |
| Halozyme Therapeutics Inc. | 20 | 0 | 0 | 0 | €52.06 | €55.13 | 5.905% |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | €104.80 | - | - |
| Amicus Therapeutics Inc. | 7 | 0 | 0 | 0 | €9.45 | €17.64 | 86.642% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €17.20 | - | - |